A phase III trial of personalized chemotherapy based on serum tumor marker decline in poor-prognosis germ-cell tumors: Results of GETUG 13.
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA4500-LBA4500
Keyword(s):
LBA4500 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Saturday, June 1, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.
2012 ◽
Vol 30
(15_suppl)
◽
pp. CRA1002-CRA1002
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA5002-LBA5002
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA3500-LBA3500
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA4024-LBA4024
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA10502-LBA10502
Keyword(s):
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA10008-LBA10008
◽
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA9008-LBA9008
◽
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA5503-LBA5503
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. 4-4
◽
Keyword(s):